TLR3 and chronic mucocutaneous candidiasis: Deficiencies in intrinsic and innate immunity accounted for another 1.11%, comprising individuals with Toll-like receptor 3 (TLR-3) deficiency and chronic mucocutaneous candidiasis (CMC).